Back to state act
Description
On 16 October 2025, the United States of America announced an agreement with EMD Serono, exempting the company from the future Section 232 pharmaceutical tariffs. In exchange for this exemption, EMD S...
Sign in or create a free account to see full description
Intervention Details
Intervention Type
Import tariff
MAST Chapter
Tariff measures
Implementation date
31 Jul 2026
Revocation date
20 Jan 2029
Implementation level
National
Affected flow
Inward
Announced as temporary
Yes
Eligible firms
firm-specific
Affected Trading Partners
Graph
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 174 products
Threads
See all
United States: Drug Pricing Agreements
This Thread tracks the U.S. Administration’s agreements with pharmaceutical companies. It is based on the Executive Order titled “Delivering Most-Favored-Nation (MFN) Prescription Drug Pricing to American Patients.” These agreements include tariff relief measures for pharmaceutical companies in return for their commitments to implement most-favored-nation pricing for their drugs and to invest i...
Published: 11 Nov 2025
93
interventions
2
jurisdictions
Liberalising Trade Policy Measures
This Thread tracks liberalising trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
15689
interventions
187
jurisdictions